1. Home
  2. ORIC vs LPAA Comparison

ORIC vs LPAA Comparison

Compare ORIC & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • LPAA
  • Stock Information
  • Founded
  • ORIC 2014
  • LPAA 2024
  • Country
  • ORIC United States
  • LPAA United States
  • Employees
  • ORIC N/A
  • LPAA N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • LPAA
  • Sector
  • ORIC Health Care
  • LPAA
  • Exchange
  • ORIC Nasdaq
  • LPAA Nasdaq
  • Market Cap
  • ORIC 362.9M
  • LPAA 296.1M
  • IPO Year
  • ORIC 2020
  • LPAA 2024
  • Fundamental
  • Price
  • ORIC $5.08
  • LPAA $10.31
  • Analyst Decision
  • ORIC Strong Buy
  • LPAA
  • Analyst Count
  • ORIC 8
  • LPAA 0
  • Target Price
  • ORIC $18.83
  • LPAA N/A
  • AVG Volume (30 Days)
  • ORIC 630.2K
  • LPAA 35.5K
  • Earning Date
  • ORIC 05-05-2025
  • LPAA 01-01-0001
  • Dividend Yield
  • ORIC N/A
  • LPAA N/A
  • EPS Growth
  • ORIC N/A
  • LPAA N/A
  • EPS
  • ORIC N/A
  • LPAA N/A
  • Revenue
  • ORIC N/A
  • LPAA N/A
  • Revenue This Year
  • ORIC N/A
  • LPAA N/A
  • Revenue Next Year
  • ORIC N/A
  • LPAA N/A
  • P/E Ratio
  • ORIC N/A
  • LPAA $48.18
  • Revenue Growth
  • ORIC N/A
  • LPAA N/A
  • 52 Week Low
  • ORIC $3.90
  • LPAA $9.66
  • 52 Week High
  • ORIC $14.67
  • LPAA $10.70
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 44.71
  • LPAA N/A
  • Support Level
  • ORIC $4.52
  • LPAA N/A
  • Resistance Level
  • ORIC $5.83
  • LPAA N/A
  • Average True Range (ATR)
  • ORIC 0.52
  • LPAA 0.00
  • MACD
  • ORIC 0.07
  • LPAA 0.00
  • Stochastic Oscillator
  • ORIC 40.58
  • LPAA 0.00

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About LPAA Launch One Acquisition Corp. Class A Ordinary shares

Launch One Acquisition Corp is a blank check company.

Share on Social Networks: